All posts
Published
October 29, 2025

Healthcare Investment: A Path to Economic Prosperity in the Global South

Spyeside team analyzes how investing in healthcare and establishing universal access pathways is crucial for accelerating societal and economic growth, especially in resource-constrained environments. Examples from the Global South demonstrate that universal coverage reforms and essential benefits packages not only improve health equity but also accelerate and sustain economic growth long-term.

Spyeside team analyzes how investing in healthcare and establishing universal access pathways is crucial for accelerating societal and economic growth, especially in resource-constrained environments. Examples from the Global South demonstrate that universal coverage reforms and essential benefits packages not only improve health equity but also accelerate and sustain economic growth long-term.

A healthy workforce and population are fundamental to a thriving economy. While the upfront costs of establishing universal healthcare can seem daunting for nations in the Global South, the long-term benefits are undeniable. By improving health outcomes and ensuring access to essential medicines, countries can unlock significant economic potential. This is a strategic investment in human capital that pays dividends in productivity, stability, and sustainable growth.

The Role of Universal Healthcare Schemes & Essential Medicines

Many countries have successfully leveraged policy changes to expand healthcare access. The introduction of Universal Healthcare Schemes (UHS) and National Lists of Essential Medicines (NLEM) are powerful examples. These policies provide a baseline level of care, ensuring that cost-effective medicines are accessible to a wider population. The key to making these initiatives effective lies in linking evidence to policy and medical practice. This is where Health Technology Assessments (HTA) become a game-changer.

Linking Policy to Growth: Key Examples

Thailand is a prime example. Since its establishment in 2007, the HTA body, HITAP, has institutionalized evidence-based practices. By linking health economics to policy, HITAP's recommendations have expanded the NLEM, which serves as the national reimbursement list. This has facilitated coverage for over 95% of Thailand's population under three public health schemes, directly supporting the nation's development goals. (Teerawattananona et.al, 2024)

Vietnam has adopted a similar approach, incorporating HTA outcomes into health insurance decisions since 2014. This strategy has been instrumental in expanding public health services, keeping pace with rapid economic growth and the increasing demands of the labor market. (Lee et.al, 2021).

In Latin America, countries like Brazil (Ortega et.al., 2023) have seen steady gains toward universal coverage through its Unified Health System, even amid fiscal austerity. Colombia (Vergara et.al., 2024) has moved toward a unified, implicitly defined benefits approach. Research in both countries has shown that when benefits policy, payment, and regulation evolve together, access expands, leading to health improvements that accumulate and support human capital formation.

Conclusion

These case studies from Asia and Latin America underscore a critical lesson: universal healthcare and essential benefits are not just social programs; they are vital economic accelerators. By adopting evidence-based frameworks like HTAs, countries in the Global South can make informed decisions that improve health equity and build a stronger, more resilient economy for the future.

Our Story

View All News
Healthcare

The Global Price Anchor: Why 2026 is the Year of the "Glocal" Drug Strategy

Speyside Group analyzes the transformative "Great Healthcare Plan" of 2026, which has fundamentally redefined Pharmaceutical Market Access by linking U.S. drug pricing to international benchmarks. This shift toward a "glocal" strategy means that negotiation outcomes in Europe or APAC now act as a direct Global Price Anchor for the American market, effectively collapsing the divide between domestic and international pricing.
Read post
Public Affairs

Venezuela's Transition: Maduro's Capture, Legal Framework, and the Race for Strategic Resources.

The Speyside Latin America team analyzes the seismic shift in Venezuela following the U.S. military operation "Operation Absolute Resolve" and the arrest of Nicolás Maduro in January 2026. This event has triggered a Crisis management scenario, resulting in a transitional government under Delcy Rodríguez subject to direct U.S. oversight. With the world's largest proven oil reserves of 303 billion barrels and vast critical mineral deposits, Venezuela presents high-stakes opportunities for investors in high growth and emerging markets. Our analysis covers the immediate bullish reaction in the energy sector—with major gains for companies like Chevron and Halliburton—and the strategic race to secure assets in the Orinoco Mining Arc. Navigating this volatile landscape requires robust Corporate Affairs strategies to manage regulatory changes and complex stakeholder engagement.
Read post
Healthcare

Prescription for 2026: What’s in store for the healthcare industry next year?

The Speyside Healthcare team forecasts that 2026 will be a year of structured reform, following a 2025 defined by sharp contrasts between rising geopolitical risks and scientific breakthroughs. As supply chains face pressure from tariffs and "Most Favoured Nation" policies, the industry requires robust Crisis management strategies to navigate pricing volatility. Our analysis highlights a critical shift in high-growth and emerging markets toward value-based healthcare, the integration of AI-driven diagnostics, and a renewed Corporate Affairs focus on the global infertility crisis.
Read post